EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency

David J Snodin iD, Alejandra Trejo-Martin, David J Ponting iD, Graham F Smith iD, Andreas Czich, Kevin Cross, Laura Custer, Joanne Elloway, Nigel Greene, Amit S Kalgutkar iD, Susanne A Stalford, Rachael E Tennant und 4 weitere

Chemical Research in Toxicology · 19.02.2024 · 37 (2) · 181-198

DOI: 10.1021/acs.chemrestox.3c00327 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemical Research in Toxicology, online erschienen am 05.02.2024. Verfasst von David J Snodin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Xiphora Biopharma Consulting, Bristol BS6 7BG, U.K. Hauptthemen laut MEDLINE: Carcinogens, Nitrosamines. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 119 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A thorough literature review was undertaken to understand how the pathways of N-nitrosamine transformation relate to mutagenic potential and carcinogenic potency in rodents. Empirical and computational evidence indicates that a common radical intermediate is created by CYP-mediated hydrogen abstraction at the α-carbon; it is responsible for both activation, leading to the formation of DNA-reactive diazonium species, and deactivation by denitrosation. There are competing sites of CYP metabolism (e.g., β-carbon), and other reactive species can form following initial bioactivation, although these alternative pathways tend to decrease rather than enhance carcinogenic potency. The activation pathway, oxidative dealkylation, is a common reaction in drug metabolism and evidence indicates that the carbonyl byproduct, e.g., formaldehyde, does not contribute to the toxic properties of N-nitrosamines. Nitric oxide (NO), a side product of denitrosation, can similarly be discounted as an enhancer of N-nitrosamine toxicity based on carcinogenicity data for substances that act as NO-donors. However, not all N-nitrosamines are potent rodent carcinogens. In a significant number of cases, there is a potency overlap with non-N-nitrosamine carcinogens that are not in the Cohort of Concern (CoC; high-potency rodent carcinogens comprising aflatoxin-like-, N-nitroso-, and alkyl-azoxy compounds), while other N-nitrosamines are devoid of carcinogenic potential. In this context, mutagenicity is a useful surrogate for carcinogenicity, as proposed in the ICH M7 (R2) (2023) guidance. Thus, in the safety assessment and control of N-nitrosamines in medicines, it is important to understand those complementary attributes of mechanisms of mutagenicity and structure-activity relationships that translate to elevated potency versus those which are associated with a reduction in, or absence of, carcinogenic potency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinogensNitrosaminesHumansAnimalsMutagensRodentiaCarcinogenesisCarbonMutagenicity Tests

Substanzen

CarcinogensNitrosaminesMutagensCarbon

Autor:innen und Institutionen

  • Xiphora Biopharma Consulting, Bristol BS6 7BG, U.K.
  • Gilead Sciences Inc. Nonclinical Safety and Pathobiology (NSP), Foster City, California 94404, United States.
  • Lhasa Limited, Granary Wharf House, Leeds, LS11 5PS, U.K.
  • AstraZeneca, Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, Research and Development, CB2 0AA Cambridge, U.K.
  • Sanofi, Research and Development, Preclinical Safety, 65926 Frankfurt, Germany.
  • Instem, Conshohocken, Pennsylvania 19428, United States.

ORCID-Profile: David J Snodin, David J Ponting, Graham F Smith, Amit S Kalgutkar, Adam Zalewski, Krista L Dobo

Zitieren

APA

Snodin, D. J., Trejo-Martin, A., Ponting, D. J., Smith, G. F., Czich, A., Cross, K., Custer, L., Elloway, J., Greene, N., Kalgutkar, A. S., Stalford, S. A., Tennant, R. E., Vock, E., Zalewski, A., Ziegler, V., & Dobo, K. L. (2024). Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency. Chemical Research in Toxicology, 37(2), 181-198. https://doi.org/10.1021/acs.chemrestox.3c00327

Vancouver

Snodin DJ, Trejo-Martin A, Ponting DJ, Smith GF, Czich A, Cross K, et al. Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency. Chemical Research in Toxicology. 2024;37(2):181-198. doi:10.1021/acs.chemrestox.3c00327

BibTeX
@article{Snodin2024,
  author = {Snodin, David J and Trejo-Martin, Alejandra and Ponting, David J and Smith, Graham F and Czich, Andreas and Cross, Kevin and Custer, Laura and Elloway, Joanne and Greene, Nigel and Kalgutkar, Amit S and Stalford, Susanne A and Tennant, Rachael E and Vock, Esther and Zalewski, Adam and Ziegler, Verena and Dobo, Krista L},
  title = {Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency},
  journal = {Chemical Research in Toxicology},
  year = {2024},
  volume = {37},
  number = {2},
  pages = {181--198},
  doi = {10.1021/acs.chemrestox.3c00327}
}
Kostenlos starten →